Back to Report Store Home

Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth

  • Published: Nov-2015
  • Report Code: GBIHC373MR
  • Report Format: pdf

Description

List of Tables

Table 1: Prostate Cancer Therapeutics, Commonly Mutated or Overexpressed Genes 12

Table 2: Prostate Cancer Therapeutics, Disease Stage Classification 15

Table 3: Prostate Cancer Therapeutics, Risk Classification for Localized Cancer, D’Amico System 16

Table 4: Prostate Cancer Therapeutics, Common Definitions of High-Risk Prostate Cancer 16

Table 5: Marketed GnRH Agonists and Their Routes of Administration for Prostate Cancer 21

Table 6: Prostate Cancer Therapeutics, Top Five European Markets, Forecast Growth in Prevalence and Treatment Populations, 2014–2021 91

Table 7: Prostate Cancer Therapeutics, Top Five European Markets, Annual Cost of Therapy ($), 2014–2021 93

Table 8: Prostate Cancer Therapeutics, Top Five European Markets, Market Size ($m), 2014–2021 95

Table 9: Prostate Cancer Therapeutics, Global, Developmental Pipeline, Discovery, 2015 112

Table 10: Prostate Cancer Therapeutics, Global, Developmental Pipeline, Preclinical, 2015 116

Table 11: Prostate Cancer Therapeutics, Global, Developmental Pipeline, IND/CTA-Filed, 2015 131

Table 12: Prostate Cancer Therapeutics, Global, Developmental Pipeline, Phase I, 2015 131

Table 13: Prostate Cancer Therapeutics, Global, Developmental Pipeline, Phase II, 2015 137

Table 14: Prostate Cancer Therapeutics, Global, Developmental Pipeline, Phase III, 2015 145

Table 15: Prostate Cancer Market, Global, Market Forecasts, 2014–2021 146

Table 16: Prostate Cancer Market, US, Market Forecasts, 2014–2021 146

Table 17: Prostate Cancer Market, Canada, Market Forecasts, 2014–2021 146

Table 18: Prostate Cancer Market, The UK, Market Forecasts, 2014–2021 147

Table 19: Prostate Cancer Market, France, Market Forecasts, 2014–2021 147

Table 20: Prostate Cancer Market, Germany, Market Forecasts, 2014–2021 147

Table 21: Prostate Cancer Market, Italy, Market Forecasts, 2014–2021 148

Table 22: Prostate Cancer Market, Spain, Market Forecasts, 2014–2021 148

Table 23: Prostate Cancer Market, Japan, Market Forecasts, 2014–2021 148

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards